Episode Details
Back to Episodes
Automation, Collaboration and the Future of Advanced Therapies
Published 3 months ago
Description
In this episode of Denatured, you'll listen to Jason Jones, head of global business development at Cellular Origins and Alexander Seyf, founder & CEO of Autolomous. They discuss how cell and gene therapy manufacturing is facing growing pressure to scale more quickly and efficiently, driving developers and manufacturers toward automation, digitization, robotics and broader collaboration across the ecosystem.
Host
Jennifer C. Smith-Parker, Director of Insights, BioSpace
Guests
Jason Jones, Head of Global Business Development, Cellular Origins
Alexander Seyf, Founder & CEO, Autolomous
Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.